Our real-world data is configured to support the evolution of your oncology portfolio
Panoramic data
Flatiron’s largest available patient cohorts are the backbone of a confident real-world evidence strategy.
Multinational data
Power global studies with interoperable data for clinical, commercial, and HTA decisions with unmatched depth in the US, UK, Germany, and Japan.
Multimodal data
Link to imaging results, genomics, pathology, claims, and other in-house or external data sources to unlock greater breadth and depth for real-world analyses.
Custom data
Collaborate with our teams of practicing oncologists, biostatisticians, and epidemiologists to curate novel variables and tailor our real-world data to your specific research needs.
Flatiron’s global network captures how patient care is actually delivered in each market
Our real-world data can help you dive deep into local patient populations, care patterns, and outcomes, but also spot meaningful differences across regions.
Confident decision-making starts with gold standard real-world data
Unmatched scale
5M+ research-ready patient records across all tumor types for robust insights into common and rare cancers.
Full patient journey
15+ years of longitudinal data to analyze treatment sequencing, key patient journey inflection points, and trends over time.
Rich clinical and molecular detail
EHR-derived clinical data combined with molecular insights to identify novel biomarkers and accelerate development.
Comprehensive endpoints
Rigorously validated outcomes for precise analysis across the entire patient journey.
Let's discuss your most complex oncology questions



